Potential novel biomarkers for monitoring the fibrogenic process in liver-Reference-Cited by-同舟云学术

Potential novel biomarkers for monitoring the fibrogenic process in liver

Published:2010-04 Issue:4 Volume:10 Page:S12-S16
ISSN:1687-1979
Container-title:Arab Journal of Gastroenterology
language:en
Short-container-title:Arab Journal of Gastroenterology

Author:

Gressner Axel M.,Rizk Mohamed,Gao Chunfang,Gressner Olav A.

Publisher

Elsevier BV

Subject

Gastroenterology

Reference27 articles.

1. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets;Gressner;J Cell Mol Med,2006

2. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases;Collazos;Clin Chim Acta,1994

3. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease;Lydatakis;Liver Int,2006

4. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum;Kropf;Clin Chem,1991

5. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1 – possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis;Flisiak;Hepato-Gastroenterol,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrosekenngrößen;Springer Reference Medizin;2019

2. Enhanced-Liver-Fibrosis-Test;Springer Reference Medizin;2019

3. Enhanced-Liver-Fibrosis-Test;Lexikon der Medizinischen Laboratoriumsdiagnostik;2017-12-04

4. Fibrosekenngrößen;Lexikon der Medizinischen Laboratoriumsdiagnostik;2017

5. Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application;Hepatobiliary & Pancreatic Diseases International;2016-04